MedPath

A feasibility study of postroperative adjuvant chemotherapy using platinum-based chemotherapy followed by maintenance TS-1 for completely resected pathologic stage II-IIIA non-small cell lung cancer with a biomarker study of circulating tumor cell

Phase 2
Recruiting
Conditions
Completely resected pathologic stage II-IIIA non-small cell lung cancer
Registration Number
JPRN-UMIN000002592
Lead Sponsor
DEPARTMENT OF THORACIC SURGERY, HYOGO COLLEGE OF MEDICINE
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
40
Inclusion Criteria

Not provided

Exclusion Criteria

Active other malignant disease

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Compliance of maintenance TS-1 administration following platinum-based chemotherapy in postoperative adjuvant setting
Secondary Outcome Measures
NameTimeMethod
Safety profile, Didsease-free survival; Overall survival; CTC-count in correlation with clinical outcome
© Copyright 2025. All Rights Reserved by MedPath